Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 407,036 |
|
|||||
| News | - | ||||||
| Day High | 4.81 | Low High |
|||||
| Day Low | 4.64 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Wave Life Sciences Ltd | WVE | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.06 | 1.27% | 4.80 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.80 | 4.64 | 4.81 | 4.66 | 4.74 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,233 | 407,036 | $ 4.72 | $ 1,920,446 | - | 2.50 - 7.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:51:37 | formt | 200 | $ 4.80 | USD |
Wave Life Sciences Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 569.84M | 122.28M | - | 3.66M | -161.82M | -1.32 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Wave Life Sciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical WVE Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.78 | 5.23 | 4.64 | 4.91 | 448,274 | 0.02 | 0.42% |
| 1 Month | 6.21 | 6.32 | 4.64 | 5.55 | 529,620 | -1.41 | -22.71% |
| 3 Months | 4.02 | 7.67 | 3.50 | 5.54 | 906,887 | 0.78 | 19.40% |
| 6 Months | 5.64 | 7.67 | 3.50 | 5.25 | 782,481 | -0.84 | -14.89% |
| 1 Year | 3.95 | 7.67 | 2.50 | 4.98 | 571,176 | 0.85 | 21.52% |
| 3 Years | 6.11 | 7.67 | 1.16 | 4.61 | 514,312 | -1.31 | -21.44% |
| 5 Years | 27.79 | 39.99 | 1.16 | 7.78 | 567,399 | -22.99 | -82.73% |
Wave Life Sciences Description
| WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. |
